Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nanopore Technologies Regulatory News (ONT)

Share Price Information for Oxford Nanopore Technologies (ONT)

Share Price is delayed by 15 minutes
Get Live Data
130.90    0.60 (0.46%)
Bid:
130.90
Ask:
133.00
Spread: 2.10 (1.604%)
Market Cap: £1.27b
ONT Live PriceLast checked at - London Stock Exchange

Intraday Oxford Nanopore Technologies Share Chart

PDMR/PCA Notification

7 Jun 2024 16:00

RNS Number : 6795R
Oxford Nanopore Technologies plc
07 June 2024
 

7 June 2024

Oxford Nanopore Technologies plc

(the "Company")

PDMR/PCA Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified that, on 7 June 2024, Jacob Henry Cowper, a Person Closely Associated with Timothy Cowper, Chief Operating Officer of the Company and a Person Discharging Managerial Responsibilities, purchased a total of 10,000 ordinary shares in the Company at a price of £1.034667 per share.

This announcement is made pursuant to the Company's obligations under Article 19 of the UK Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jacob Henry Cowper

2

Reason for the notification

a)

Position/status

Person Closely Associated with Timothy Cowper, Chief Operating Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Purchase of shares in the Company

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£1.034667

10,000

d)

Aggregated information

- Aggregated volume

 - Aggregated price

10,000

£10,346.67

e)

Date of the transaction

7 June 2024

f)

Place of the transaction

London Stock Exchange (XLON)

[ENDS]

Enquiries:

Investors

ir@nanoporetech.com 

Media 

media@nanoporetech.com

OxfordNanoporeTechnologies@teneo.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUBVSRSSUNRAR
Date   Source Headline
15th Oct 20247:00 amRNSIssue of Equity and Total Voting Rights
14th Oct 202410:00 amRNSAdmission to Trading on the London Stock Exchange
11th Oct 20244:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
10th Oct 20248:00 amRNSNew issue in connection with LTIP awards
8th Oct 20247:00 amRNSNotice of intention to transfer listing category
7th Oct 20246:15 pmRNSBlock Listing Interim Review
2nd Oct 20249:00 amRNSIssue of Equity and Total Voting Rights
1st Oct 20247:00 amRNSDaniel Mahony appointed as Non-Executive Director
13th Sep 20244:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
10th Sep 20247:00 amRNSSeeks discovery into expected breach of contract
3rd Sep 202412:00 pmRNSIssue of Equity and Total Voting Rights
3rd Sep 202412:00 pmRNSHolding(s) in Company
3rd Sep 20247:00 amRNSInterim results for the 6 months ended 30 June 24
30th Aug 20242:00 pmRNSNotice of Interim Results Presentation
20th Aug 20243:00 pmRNSHolding(s) in Company
15th Aug 20247:00 amRNSHolding(s) in Company
14th Aug 20247:00 amRNSHolding(s) in Company
13th Aug 20245:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
9th Aug 20245:30 pmRNSHolding(s) in Company
9th Aug 20243:00 pmRNSDirector Declaration
7th Aug 20245:30 pmRNSHolding(s) in Company
7th Aug 20242:00 pmRNSHolding(s) in Company
5th Aug 202412:30 pmRNSAdmission of Ordinary Shares & Total Voting Rights
1st Aug 20245:30 pmRNSIssue of Equity and Total Voting Rights
1st Aug 20247:00 amRNSInvestment from Novo Holdings and Equity Issue
31st Jul 20244:58 pmRNSInvestment from Novo Holdings and proposed placing
24th Jul 20247:00 amRNSHalf Year Trading Update
16th Jul 20247:00 amRNSAppointment of corporate broker
11th Jul 20244:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
3rd Jul 20245:30 pmRNSFounder LTIP - Director/PDMR Notification
1st Jul 20244:30 pmRNSTotal Voting Rights
28th Jun 20244:30 pmRNSFounder LTIP - Director/PDMR Notification
21st Jun 20245:33 pmRNSIssue of Equity and Total Voting Rights
21st Jun 202410:00 amRNSAdmission to Trading on the London Stock Exchange
19th Jun 20247:00 amRNSIssue of Equity
11th Jun 20244:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
10th Jun 20244:00 pmRNSResult of AGM; Director Responsibilities
7th Jun 20244:00 pmRNSPDMR/PCA Notification
3rd Jun 20244:00 pmRNSIssue of Equity and Total Voting Rights
23rd May 20248:00 amRNSLondon Calling Technology Update
13th May 20244:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st May 20245:00 pmRNSIssue of Equity and Total Voting Rights
1st May 20247:00 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSPublication of Annual Report and Notice of AGM
12th Apr 20241:00 pmRNSStudy unlocks insights into disease and longevity
12th Apr 202412:00 pmRNSLTIP and DBP; Director/PDMR Notification
11th Apr 20244:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
8th Apr 20244:00 pmRNSBlock Listing Interim Review
2nd Apr 20242:00 pmRNSIssue of Equity and Total Voting Rights
28th Mar 20245:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.